Diabetes Mellitus Clinical Trial
— LIFeOfficial title:
Lifestyle Intervention for African-American Women: A Pilot Study for Women With a Recent History of Gestational Diabetes (The LIFe Study)
| Verified date | January 2016 |
| Source | Brigham and Women's Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
Women with a history of gestational diabetes (GDM) have a substantially increased risk of
developing type 2 diabetes. In fact, 50-70% of these women will go on to develop type 2
diabetes within the 20 years following their GDM-complicated pregnancy. Perceived risk of
developing type 2 diabetes among women with a history of GDM may be particularly important
to altering behavior changes associated with reducing risk. Certain populations have lower
perceived risk of developing type 2 diabetes, despite having a higher prevalence of the
disease. Specifically, African-Americans have a lower perceived risk of developing type 2
diabetes compared to whites, despite their more than doubled risk of developing the disease.
Improvement in awareness of diabetes risk among African-American women at high-risk of
developing type 2 diabetes, such as those with a history of GDM, could reduce future risk of
this disease among this group.
As such, we will conduct a two-armed, pilot randomized controlled trial to evaluate whether
a postpartum diabetes education intervention, incorporating nutrition, exercise, and
diabetes risk assessment can improve diabetes risk awareness, diet, and physical activity
levels at 1-year post-pregnancy among African-American women with a recent history of
gestational diabetes.
We hypothesize that attendance at a 3-month and 9-month postpartum diabetes education class
will:
1. Improve diabetes awareness as measured using the Risk Perception for Developing
Diabetes among women in the intervention group compared to women in the control group
when measuring at 3-months postpartum compared to 12-months postpartum
2. Improve dietary habits and physical activity levels in the intervention group compared
to the control group when measuring at 3-months postpartum compared to 12-months
postpartum
| Status | Completed |
| Enrollment | 15 |
| Est. completion date | July 2015 |
| Est. primary completion date | July 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years to 55 Years |
| Eligibility |
Inclusion Criteria: - Have gestational diabetes during current or most recent pregnancy - Be less than 3 months postpartum - Age between >=18 years - Preconception BMI <45 - Singleton pregnancy - Self-identified Black/African-American race/ethnicity - Speak English Exclusion Criteria: - Preexisting diabetes or diabetes diagnosed at the 6 week 75 gram oral glucose tolerance test. - BMI >=45. - Multiple gestation (i.e. twins, triplets, etc.) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| United States | Brigham and Women's Hospital | Boston | Massachusetts |
| Lead Sponsor | Collaborator |
|---|---|
| Brigham and Women's Hospital |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Change in diabetes risk awareness from baseline to 9 months | 3 months to 9 months postpartum | No | |
| Other | Change in diet patterns from baseline to 9 months postpartum | 3 months to 9 months postpartum | No | |
| Other | Change in physical activity levels from baseline to 9 months postpartum | 3 months to 9 months postpartum | No | |
| Other | Change in diabetes risk awareness from baseline to 6 months postpartum | 3 to 6 months postpartum | No | |
| Other | Change in diet patterns from baseline to 6 months postpartum | 3 to 6 months postpartum | No | |
| Other | Change in physical activity levels from baseline to 6 months postpartum | 3 to 6 months postpartum | No | |
| Primary | Change in Diabetes Risk Awareness from baseline to 12 months postpartum | Using an adapted version of the Risk Perception Survey for Developing Diabetes for women with a history of gestational diabetes, women will be asked to respond on web-based or paper questionnaires regarding their individual and group risk of getting diabetes. The primary outcome will measure the change in their awareness of diabetes based on their diabetes risk perception score at baseline (3 months postpartum) compared to 12 months postpartum. | 3-12 months postpartum | No |
| Secondary | Change in diet patterns from baseline to 12 months postpartum | Women will be asked to respond to a adapted food frequency questionnaire. This food frequency questionnaire has been previously used in postpartum populations and is correlated with various health outcomes in observational studies. Diet information will be asked using the same food frequency questionnaire multiple times and the difference between baseline (3 months postpartum) and 12 months postpartum will be measured. | 3 months to 12 months postpartum | No |
| Secondary | Change in physical activity levels from baseline to 12 months postpartum | Women will be asked to respond to questions regarding their physical activity level using an adapted physical activity questionnaire from the Nurses' Health Study. These questions will be adapted for use in a postpartum, African-American population. Women will be asked about their physical activity levels multiple times and the difference between physical activity levels at baseline (3 months) and at 12 months postpartum will be measured. | 3 to 12 months postpartum | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |